The all-in-one container and injection device for vaccines.
SCHOTT Pharma is one of the leading companies developing high quality prefillable glass syringes (PFS). A common FIOLAX® glass base combined with a deep understanding of syringe systems helps smooth the transition from vials to syringes.
The ready-to-use syriQ® glass PFS ensure safety and efficiency by eliminating almost all drug injection preparation steps. Extensive options, including the proven syriQ® Rigid Cap (SRC) closure system, allow syriQ® to be perfectly tailored to individual vaccine requirements.
syriQ® glass PFS are supported by continuous development programs to meet the needs of emerging drug technology platforms and customer-specific projects – from traditional inactivated vaccines to breakthrough mRNA solutions.
Optimum safety and convenience for patients with syriQ®
syriQ® glass PFS deliver safety and convenience to patients and healthcare providers.
They are ideal for storing and injecting a broad range of vaccines, including:
– inactivated vaccines, such as those used against influenza
– live-attenuated vaccines, such as the MMR combined vaccine
– subunit, recombinant, polysaccharide, and conjugate vaccines, such as the HPV vaccine
– breakthrough mRNA vaccines
– syriQ® prefillable glass syringes can also be used in diluent applications.
Stable storage and easy processing.
Offering stable storage and enhanced vaccine shelf life, syriQ® glass PFS are made of FIOLAX® Borosilicate Glass and offer a range of benefits.
– Tight dimensional tolerances to ensure accurate filling and functionality.
– Proven container closure integrity and reliable functionality of standard and emerging drug models down to -50 °C.
– Delivered in standard nests as part of the SCHOTT iQ® platform for easy processing on standard filling lines.
– Comprehensive portfolio, including pre-tested closure and plunger components, to support customization for drug and fill-and-finish requirements.
